亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

成都鈉鈳鋰生物科技有限公司  

自制標準品對照品,各類植物提取物

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:李曼
  • 電話:028-61983833
  • 郵件:cdnakeli@163.com
  • 微信:18000507060
  • QQ:1373789011
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 紫草***苷 CAS:63492-69-3
紫草***苷 CAS:63492-69-3
單價 面議對比
詢價 暫無
發貨 四川成都市付款后3天內
品牌 鈉鈳鋰
過期 長期有效
更新 2021-11-25 12:21
 
詳細信息

nkl-01145

中文名稱:紫草***苷
英文名稱: Lithospermoside
英文別名: Griffonin
CAS號:63492-69-3
純度: HPLC≥95%

分子式:C14H19NO8
分子量:329.30
外觀:白色絮狀結晶
熔點: 271 °C (de*p) | Condition: Solv: ethyl acetate (141-78-6); methanol (67-56-1)
沸點: 662.4±55.0 °C | Condition
密度: 1.61±0.1 g/cm3 | Condition: Temp: 20 °C
pKa 值: 12.71±0.60 | Condition: Most Acidic Temp: 25 °C
提取來源:紫草
藥理藥效:解熱、解毒、抗炎癥藥

規格:10mg,20mg,50mg;可根據客戶需求包裝、定制

儲存條件: 低溫,避光、干燥、密封

用途: 用于鑒別、含量測定、藥理實驗、活性篩選等科研、實驗室使用;不得直接用于人體

供應商:成都鈉鈳鋰生物科技有限公司

©2025 成都鈉鈳鋰生物科技有限公司 版權所有   技術支持:化工網   訪問量:21482  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |